CD4+ T and B cell mechanisms of influenza vaccine non-responsiveness in older adu

老年人流感疫苗无反应的 CD4 T 和 B 细胞机制

• 批准号: 8788501
• 负责人: Michael R Betts
• 金额: $ 46.3万
• 依托单位: CASE WESTERN RESERVE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8788501
• 关键词: Accounting; Address; Aging; Antibodies; Antibody Affinity; Avidity; B-Lymphocyte Subsets; B-Lymphocytes; Biopsy; Blood; Blood specimen; CD4 Positive T Lymphocytes; Cells; Centers for Disease Control and Prevention (U.S.); Cessation of life; Data; Defect; Development; Elderly; Failure; Frequencies; Gene Expression Profile; Genetic Transcription; Health; Helper-Inducer T-Lymphocyte; Hemagglutinin; Hospitalization; Human; Humoral Immunities; Immune; Immune response; Immunoglobulin Somatic Hypermutation; Immunologics; Individual; Influenza; Influenza vaccination; Light; Measures; Memory B-Lymphocyte; Morbidity - disease rate; Mus; Older Population; Phenotype; Population; Population Control; Property; Public Health; Relative (related person); Structure of germinal center of lymph node; Study models; T-Lymphocyte; Tissues; Translating; Vaccinated; Vaccination; Vaccines; base; exhaust; flu; influenza virus vaccine; innovation; lymph nodes; mortality; peripheral blood; programs; response; senescence; vaccine response

DESCRIPTION (provided by applicant): According to the CDC, there are over 20,000 deaths and 200,000 hospitalizations due to influenza each year, 90% of which were in people over age 65. The administration of the seasonal trivalent inactivated influenza vaccine remains the primary public health measure recommended by the CDC; however, this vaccine has significantly reduced efficacy, often below 50%, in this older population that needs protection most. Thus, a better understanding of immunologic and vaccination failure is urgently needed to develop better strategies to reduce influenza-related morbidity and mortality in older adults. At the tissue level, the underlying mechanisms of vaccine failure--immunologic non-responsiveness to influenza vaccination--in older adults remain to be defined. Most key immunologic responses to vaccination occur within regional draining lymph nodes (LN), not the peripheral blood. In light of this, the central novelty and innovation of this proposal is to defin the underlying B and T cell properties within the regional draining LN that can account for immunologic non- responsiveness and vaccination failure in older adults. Here we propose direct examination of influenza vaccine-induced CD4+ T and B cells within proximal LN biopsies obtained after vaccination. Recent studies in mice have identified T follicular helper (Tfh) cells key role in the development of the germinal center in the LN after vaccination to provide optimal stimulation of B lymphocytes for the development of long lasting humoral immunity with high affinity antibodies. Our preliminary data suggest that Tfh cells in blood decline with aging, but more-so for the subset of older adults who fail to respond to influenza vaccine. As such, we hypothesize that defects in T follicular helper cell (Tfh) and T helper type 1 (Th1) transcription programming, levels, phenotype, and function result in reduced antibody quantity and quality after influenza vaccination in older adults, clinically translating to non- responsiveness and vaccine failure. Moreover, we hypothesize that these defects will be most pronounced in older vaccine non-responders and contribute to the immunosenescent phenotype observed in older persons. We will address these hypotheses in the following Specific Aims: Aim 1: To determine if baseline differences in total and flu-specific CD4+ Th1/Tfh subsets and B cells in LN and blood prior to vaccination predict old influenza vaccine failures/non-responders (NR) and old vaccine-responders (R). Aim 2: To determine the specific defects in the induction of CD4+ Th1/Tfh cell and B cell responses in regional LN and blood acutely after influenza vaccination that result in the old influenza vaccine NR and R phenotypes.

描述（由申请人提供）：根据CDC，每年有超过20，000人死亡，200，000人因流感住院，其中90%是65岁以上的人。季节性三价灭活流感疫苗的管理仍然是CDC推荐的主要公共卫生措施;然而，这种疫苗在最需要保护的老年人群中的有效性显著降低，通常低于50%。因此，迫切需要更好地了解免疫和疫苗接种失败，以制定更好的策略，减少老年人流感相关的发病率和死亡率。 在组织水平上，老年人疫苗失败的潜在机制--对流感疫苗接种的免疫无反应性--仍有待确定。对疫苗接种的大多数关键免疫应答发生在区域引流淋巴结（LN）中，而不是外周血中。鉴于此，该提议的中心新奇和创新性在于确定区域引流LN内的潜在B和T细胞性质，其可以解释老年人中的免疫无应答性和疫苗接种失败。在这里，我们建议直接检查流感疫苗诱导的CD 4 + T和B细胞接种后获得的近端LN活检。 最近在小鼠中的研究已经鉴定了T滤泡辅助（Tfh）细胞在接种后LN中的生发中心的发育中的关键作用，以提供B淋巴细胞的最佳刺激，用于用高亲和力抗体发展持久的体液免疫。我们的初步数据表明，血液中的Tfh细胞随着年龄的增长而下降，但对于对流感疫苗没有反应的老年人来说，情况更是如此。因此，我们假设T滤泡辅助细胞（Tfh）和T辅助1型（Th 1）转录编程、水平、表型和功能的缺陷导致老年人接种流感疫苗后抗体数量和质量降低，临床上转化为无反应性和疫苗失败。此外，我们假设这些缺陷在老年疫苗无应答者中最为明显，并导致在老年人中观察到的免疫衰老表型。我们将在以下具体目的中阐述这些假设：目的1：确定接种前LN和血液中总的和流感特异性CD 4 + Th 1/Tfh亚群和B细胞的基线差异是否可预测旧流感疫苗失败/无应答者（NR）和旧疫苗应答者（R）。目标二：确定流感疫苗接种后急性诱导局部LN和血液中CD 4 + Th 1/Tfh细胞和B细胞应答的特异性缺陷，导致旧流感疫苗NR和R表型。